104795-56-4Relevant articles and documents
HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS
-
Paragraph 000189, (2015/10/05)
ABSTRACT The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
Endothelin receptor antagonists: Synthesis and structure-activity relationships of substituted benzothiazine-1,1-dioxides
Berryman,Edmunds,Bunker,Haleen,Bryant,Welch,Doherty
, p. 1447 - 1456 (2007/10/03)
The development of benzothiazine-1,1-dioxide derivatives as a new structural class of potent endothelin receptor antagonists is described. Structure-activity relationships (SAR) revealed that PD164800 (1) is a potent antagonist of the ET(A) receptor subtype. Copyright (C) 1998 Elsevier Science Ltd.